Diagnosis and treatment of COVID-19 in primary healthcare

Darinka Punoševac, Sandra Vesić-Veškovac
{"title":"Diagnosis and treatment of COVID-19 in primary healthcare","authors":"Darinka Punoševac, Sandra Vesić-Veškovac","doi":"10.5937/opmed28-34491","DOIUrl":null,"url":null,"abstract":"COVID-19 pandemic is caused by the SARS-Cov-2 virus and it was first isolated in Wuhan, China, in December 2019. In Primary Healthcare Center (PHC), Krusevac, the outpatient clinic for respiratory infections was formed on March 24th, 2020. Nearly 100.000 medical exams were performed there, up till now. The virus transmission is carried out by airborne droplets, or rarely using contaminated hands. The entrance site of the infection is nose, mouth, or eye mucose. The infection develops in two stages. The first happens in the upper respiratory tract (URT) and lasts 5-7 days, and the second, when the virus descends to the lungs, and from there causes systemic inflammation, primarily of the blood vessels. The diagnosis is based on the personal history, clinical presentation, physical exam, specific viral tests, lab analysis, and eventually, chest X-ray. Therapy is mainly symptomatic, and since March 2021 we got antiviral favipiravir, and in January 2022 another antiviral, molnupiravir, became available. Oral corticosteroids showed promising results in patients with viral pneumonia. Primary healthcare was a dam against the secondary and tertiary healthcare this time, too. As our colleagues worldwide, we were learning in stride, and the process is ongoing. The more people get exposed to the virus, either naturally or by vaccination, the sooner the pandemic will end but not entirely and probably stay with us as a seasonal infection with easier clinical presentation.","PeriodicalId":31567,"journal":{"name":"Opsta Medicina","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Opsta Medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/opmed28-34491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

COVID-19 pandemic is caused by the SARS-Cov-2 virus and it was first isolated in Wuhan, China, in December 2019. In Primary Healthcare Center (PHC), Krusevac, the outpatient clinic for respiratory infections was formed on March 24th, 2020. Nearly 100.000 medical exams were performed there, up till now. The virus transmission is carried out by airborne droplets, or rarely using contaminated hands. The entrance site of the infection is nose, mouth, or eye mucose. The infection develops in two stages. The first happens in the upper respiratory tract (URT) and lasts 5-7 days, and the second, when the virus descends to the lungs, and from there causes systemic inflammation, primarily of the blood vessels. The diagnosis is based on the personal history, clinical presentation, physical exam, specific viral tests, lab analysis, and eventually, chest X-ray. Therapy is mainly symptomatic, and since March 2021 we got antiviral favipiravir, and in January 2022 another antiviral, molnupiravir, became available. Oral corticosteroids showed promising results in patients with viral pneumonia. Primary healthcare was a dam against the secondary and tertiary healthcare this time, too. As our colleagues worldwide, we were learning in stride, and the process is ongoing. The more people get exposed to the virus, either naturally or by vaccination, the sooner the pandemic will end but not entirely and probably stay with us as a seasonal infection with easier clinical presentation.
初级卫生保健中COVID-19的诊断和治疗
COVID-19大流行是由SARS-Cov-2病毒引起的,于2019年12月在中国武汉首次分离出来。在克鲁塞瓦茨初级卫生保健中心(PHC),呼吸道感染门诊于2020年3月24日成立。到目前为止,在那里进行了近10万次体检。病毒通过空气中的飞沫传播,很少使用受污染的手。感染的入口部位是鼻、口或眼粘膜。感染分两个阶段发展。第一阶段发生在上呼吸道(URT),持续5-7天,第二阶段,当病毒下降到肺部,并从那里引起全身炎症,主要是血管。诊断是基于个人病史、临床表现、体格检查、特定病毒测试、实验室分析,最后是胸片。治疗主要是对症治疗,自2021年3月以来,我们获得了抗病毒药物favipiravir,并于2022年1月获得了另一种抗病毒药物molnupiravir。口服皮质类固醇在病毒性肺炎患者中显示出良好的效果。这一次,初级保健也是阻碍二级和三级保健的大坝。作为我们在世界各地的同事,我们正在大步学习,这个过程还在继续。越多的人接触到这种病毒,无论是自然地还是通过接种疫苗,大流行就会越早结束,但不会完全结束,而且很可能作为一种季节性感染与我们在一起,更容易出现临床表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
2
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书